Genius Sports Limited (GENI) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.64%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.64% | Research and development expense / revenue. Period ending 2025-12-31. $31.09M ÷ $669.49M × 100 ≈ 4.64% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 31.09M USD | Research and Development Expense |
| Revenue | 669.49M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | -151.33M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $31.09M | $669.49M | (m) | $-151.33M | (m) | 4.64% | (m) | (m) | (m) |
| 2024-12-31 | $24.58M | $510.89M | (m) | $-58.54M | (m) | 4.81% | (m) | (m) | (m) |
| 2023-12-31 | $26.07M | $412.98M | (m) | $-74.16M | (m) | 6.31% | (m) | (m) | (m) |
| 2023-06-30 | $26.85M | $368.06M | (m) | $-109.05M | (m) | 7.29% | (m) | (m) | (m) |
| 2022-12-31 | $29.89M | $341.03M | (m) | $-182.87M | (m) | 8.77% | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $26.51M | $262.74M | (m) | $-573.29M | (m) | 10.09% | (m) | (m) | (m) |
| 2020-12-31 | $11.24M | $149.74M | (m) | $-21.04M | (m) | 7.51% | (m) | (m) | (m) |
| 2019-12-31 | $13.29M | $114.62M | (m) | $-36.19M | (m) | 11.59% | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-07 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.